Literature DB >> 14376703

Pathogenicity and immunology of Newcastle disease virus (NVD) in man.

A S EVANS.   

Abstract

Entities:  

Keywords:  NEWCASTLE DISEASE/virus

Mesh：

Year:  1955        PMID： 14376703      PMCID： PMC1623084          DOI： 10.2105/ajph.45.6.742

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  8 in total

1.  Blood stream invasion by Newcastle disease virus associated with hemolytic anemia and encephalopathy; report of three cases.

Authors:  S E MOOLTEN; E CLARK; B F GLASSER; E KATZ; B S MILLER
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

2.  AMERICAN Association of Immunologists, Thirty-seventh Annual Meeting, Chicago, Illinois, April 6-10, 1953.

Authors: 
Journal:  Fed Proc       Date:  1953-03

3.  Presence of neutralizing antibodies of Newcastle disease virus in human sera.

Authors:  B F HOWITT; L K BISHOP; R E KISSLING
Journal:  Am J Public Health Nations Health       Date:  1948-09

4.  The occurrence of Newcastle disease antihemagglutinin in human sera and its relationship to mumps virus.

Authors:  A S EVANS
Journal:  J Immunol       Date:  1951-12       Impact factor: 5.422

5.  Viremia in acute hemolytic anemia and in autohemagglutination; report of a case and review of the literature, with special reference to the virus of newcastle disease.

Authors:  S E MOOLTEN; E CLARK
Journal:  AMA Arch Intern Med       Date:  1952-02

6.  Human infection with the Newcastle virus of fowls.

Authors:  A H KEENEY; M C HUNTER
Journal:  AMA Arch Ophthalmol       Date:  1950-10

7.  The determination and significance of substances neutralizing Newcastle virus in human serum.

Authors:  F B BANG; M FOARD; D T KARZON
Journal:  Bull Johns Hopkins Hosp       Date:  1950-08

8.  Neutralization of viruses by homologous immune serum. I. Quantitative studies on factors which affect the neutralization reaction with Newcastle disease, influenza A, and bacterial virus T3.

Authors:  D A TYRRELL; F L HORSFALL
Journal:  J Exp Med       Date:  1953-06       Impact factor: 14.307
  8 in total
  5 in total

1.  The human pathogenicity of the Newcastle disease virus and its relation to the mumps, fowl plague and influenza viruses.

Authors:  J SINKOVICS
Journal:  Arch Gesamte Virusforsch       Date:  1957

Review 2.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy.

Authors:  P R A Buijs; G van Amerongen; S van Nieuwkoop; T M Bestebroer; P R W A van Run; T Kuiken; R A M Fouchier; C H J van Eijck; B G van den Hoogen
Journal:  Cancer Gene Ther       Date:  2014-09-26       Impact factor: 5.987

4.  Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.

Authors:  Ekaterina G Viktorova; Sunil K Khattar; Diana Kouiavskaia; Majid Laassri; Tatiana Zagorodnyaya; Eugenia Dragunsky; Siba Samal; Konstantin Chumakov; George A Belov
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

5.  Isolation of avian paramyxovirus 1 from a patient with a lethal case of pneumonia.

Authors:  Scott J Goebel; Jill Taylor; Bradd C Barr; Timothy E Kiehn; Hugo R Castro-Malaspina; Cyrus V Hedvat; Kim A Rush-Wilson; Cassandra D Kelly; Stephen W Davis; William A Samsonoff; Kelley R Hurst; Melissa J Behr; Paul S Masters
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.